BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:The 6th TPD and Induced Proximity Summit Europe is the only Eu ropean forum dedicated exclusively to proximity-based drug discovery. Fro m PROTACs and molecular glues to stabilizers and extracellular degraders\ , this summit showcases the full spectrum of therapeutic innovation acros s oncology\, neurodegeneration\, immunology\, and rare diseases. Held in London in March 2026\, the event brings together more than 80 CxOs\, dire ctors\, senior scientists and investors to accelerate proximity therapeut ics from discovery to clinic.\n\nEurope is experiencing a surge in strate gic investment and innovation\, including Sanofi’s acquisition of Bluepri nt Medicines for £7.2 billion and Merck’s £2.7 billion purchase of Spring Works Therapeutics. As the region pivots toward non-oncology indications and novel mechanisms\, drug developers face challenges in rational design \, oral bioavailability\, PK and PD modelling\, and clinical translation. This summit addresses those challenges with insights from leading compan ies such as GSK\, Abbvie\, Amphista\, Autotac Bio\, PhoreMost\, Laigo Bio \, and Foghorn Therapeutics. Attendees will gain access to first-in-human data\, biology-first strategies\, and novel degradation platforms that a re redefining the druggable proteome.\n\nWhether you are advancing early discovery or preparing clinical candidates\, this is your essential oppor tunity to connect with Europe's most innovative biopharma teams and stay ahead in the evolving induced proximity landscape.\n\nURLs:Tickets: \ ;https://go.evvnt.com/3355369-2?pid=185 \;Brochure: \;https://go. evvnt.com/3355369-3?pid=185 \;\n\nDate and Time: Tue\, 10 Mar 2026 08 :00 - Thu\, 12 Mar 2026 18:00\n\nVenue details: Millennium Hotel and Conf erence Centre Gloucester London\, 4-18 Harrington Gardens\, London\, Engl and\, SW7 4LH\, United Kingdom\n\nCategory: Conferences | Science\, Healt h &\; Medicine | Pharmaceuticals | Drug Discovery\n\nPrices:Drug Devel oper Pricing - 3 Day Pass (Conference + Workshop Day): GBP 3797.00\,Drug Developer Pricing - 2 Day Pass (Conference Only): GBP 2699.00\,Academic P ricing - 3 Day Pass (Conference + Workshop Day): GBP 3197.00\,Academic Pr icing - 2 Day Pass (Conference Only): GBP 2299.00\,Service Provider Prici ng - 3 Day Pass (Conference + Workshop Day): GBP 4497.00\,Service Provide r Pricing - 2 Day Pass (Conference Only): GBP 3199.00\n\n \;\n\nSpeak ers: Georg Winter\, Life Science Director\, AITHYRA Institute for Biomedi cal AI\, Victor Guallar\, ICREA Professor and Group Leader\, Barcelona Su percomputing Group\, Zoran Rankovic\, Director and Professor - Chemical B iology and Protein Degradation\, Center for Protein Degradation\, Institu te of Cancer Research\, Radoslaw Nowak\, Professor of Immune Engineering and Drug Discovery\, The University of Bonn\, Alessio Ciulli\, Founder\, Director and Professor - Chemical\, Structural Biology and Centre for Tar geted Protein Degradation\, University of Dundee\, Laura Gasparini\, Scie ntific Director and Tau Pathobiology Area Leader\, Abbvie\, Christopher W oelk\, External Innovation Partner\, Astellas Pharma\, Carlos Martinez\, Fleites Scientific Leader\, Molecular Modalities Discovery\, GlaxoSmithKl ine\, Christin Rakers\, Principal Scientist Computational Chemistry\, Mer ck\, Björn Niebel\, Senior Principal Scientist\, Sanofi\, Large Molecule Research\, Damian Crowther\, Entrepreneur In Residence\, Cambridge Innova tion Capital and SV Health Investors DDF\, Mary Canning\, Partner\, Epida rex Capital\, Luka Nicin\, Venture Capitalist\, Pace Ventures\, Tiziana R osetti\, Principal\, Sofinnova Partners\, Christian Ottmann\, Associate P rofessor\, Ambagon Therapeutics\, Louise Modis\, Chief Scientific Officer \, Amphista\, Changhoon Ji\, Chief Technology Officer\, Autotac Bio\, Geo rge Crane\, Co-Founder and Chief Executive Officer\, Bindbridge\, Simon G lerup\, Chief Scientific Officer\, Draupnir Bio\, Shyra Gardai\, Chief Sc ientific Officer\, EpiBiologics\, Jamie Im\, Director\, Medicinal Chemist ry\, Foghorn Therapeutics\, Ian Churcher\, CEO and Founder\, Janus Drug D iscovery Consulting\, Maureen Galmes-Spit\, Vice President - Research\, L aigo Bio\, Christian Dillon\, Chief Scientific Officer\, PhoreMost\, Kiri ll Pevzner\, Chief Technology Officer and Co-Founder\, Protai Bio\, Chris Tame\, Founder and Chief Executive Officer\, Ternary Therapeutics\, Mart in Stahl\, Chief Scientific Officer\, Zenith Therapeutics\n DTEND:20260312T180000 DTSTAMP:20260512T214302Z DTSTART:20260310T080000 LOCATION:Millennium Hotel and Conference Centre Gloucester London\, 4-18 Harrington Gardens \, London\, England\, SW7 4LH \, SEQUENCE:0 SUMMARY:The 6th TPD and Induced Proximity Summit Europe is the only Europe an forum dedicated exclusively to proximity-based drug discovery. From PR OTACs an... UID:e63654aa-dc76-4d10-89e2-234a51d73957 END:VEVENT END:VCALENDAR